Thoratec, a world leader in products to treat cardiovascular disease, recently
said that it has received approval to CE Mark its HeartMate II LVAS (Left Ventricular
Assist System), allowing the commercial launch of the device in Europe. The
company said it expects to initiate product sales activities in the market before
the end of the year.